glycerophosphoinositol 4,5-bisphosphate has been researched along with Thrombotic Microangiopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attanasio, M; Chauhan, AK; Dai, DF; Ding, Q; Huang, CL; Jin, H; Li, C; Liu, D; Nayak, MK; Padhy, B; Purvis, M; Shu, C | 1 |
1 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Thrombotic Microangiopathies
| Article | Year |
|---|---|
Loss of diacylglycerol kinase ε causes thrombotic microangiopathy by impairing endothelial VEGFA signaling.
Topics: Animals; Atypical Hemolytic Uremic Syndrome; Autocrine Communication; Cyclooxygenase 2; Diacylglycerol Kinase; Dinoprostone; Endothelium, Vascular; Gene Knockdown Techniques; Glomerular Filtration Barrier; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Phosphatidylinositol 4,5-Diphosphate; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; Thrombotic Microangiopathies; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2021 |